晚期非小细胞肺癌靶向治疗进展(3)
[5] Rosell R.Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC)：a multicentre，open-label，randomised phase 3 trial[J].Lancet Oncol，2012，13(3)：239-246.[6] Lee SY.Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers[J].J Thorac Oncol ......
您现在查看是摘要页，全文长 2935 字符。